<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a 65-year-old female with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) who has attended our O.P.D. since 1983 </plain></SENT>
<SENT sid="1" pm="."><plain>In early December, 1990, <z:hpo ids='HP_0002094'>dyspnea</z:hpo> on effort developed which then progressed to <z:hpo ids='HP_0002094'>dyspnea</z:hpo> at rest at the end of December </plain></SENT>
<SENT sid="2" pm="."><plain>She was admitted on January 8 with orthopnea </plain></SENT>
<SENT sid="3" pm="."><plain>Chest X-ray films revealed loss of vascular shadows of the right lung </plain></SENT>
<SENT sid="4" pm="."><plain>Blood gas analysis showed hypoxemia and hypocapnemia </plain></SENT>
<SENT sid="5" pm="."><plain>Abnormalities in the coagulation-fibrinolytic system (increased TAT (thrombin-anti-thrombin III complex) and alpha 2-PIC (plasmin inhibitor complex)), possibly due to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, were detected </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnosis of pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> was made by pulmonary perfusion scintigram and pulmonary arteriography </plain></SENT>
<SENT sid="7" pm="."><plain>After commencement of anticoagulation therapy on January 15, the subjective symptoms, blood gas analysis, pulmonary scintigram, and disorders of the coagulation-fibrinolytic system improved </plain></SENT>
<SENT sid="8" pm="."><plain>The patient was discharged on March 5, 1991 </plain></SENT>
<SENT sid="9" pm="."><plain>The present case of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> was associated with abnormalities of the coagulation-fibrinolytic system and was complicated by pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
</text></document>